MSB 2.98% $1.47 mesoblast limited

well the FDA has rejected even on a 2nd Type A review.so unsure...

  1. 961 Posts.
    lightbulb Created with Sketch. 166
    well the FDA has rejected even on a 2nd Type A review.

    so unsure how you say there is no problem when the FDA categorically say there is a problem.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.